Direkt zum Inhalt
Merck
  • Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.

Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.

Neoplasia (New York, N.Y.) (2014-11-27)
Changsheng Xing, Xinpei Ci, Xiaodong Sun, Xiaoying Fu, Zhiqian Zhang, Eric N Dong, Zhao-Zhe Hao, Jin-Tang Dong
ZUSAMMENFASSUNG

Krüppel-like factor 5 (KLF5) regulates multiple biologic processes. Its function in tumorigenesis appears contradictory though, showing both tumor suppressor and tumor promoting activities. In this study, we examined whether and how Klf5 functions in prostatic tumorigenesis using mice with prostate-specific deletion of Klf5 and phosphatase and tensin homolog (Pten), both of which are frequently inactivated in human prostate cancer. Histologic analysis demonstrated that when one Pten allele was deleted, which causes mouse prostatic intraepithelial neoplasia (mPIN), Klf5 deletion accelerated the emergence and progression of mPIN. When both Pten alleles were deleted, which causes prostate cancer, Klf5 deletion promoted tumor growth, increased cell proliferation, and caused more severe morphologic and molecular alterations. Homozygous deletion of Klf5 was more effective than hemizygous deletion. Unexpectedly, while Pten deletion alone expanded basal cell population in a tumor as reported, Klf5 deletion in the Pten-null background clearly reduced basal cell population while expanding luminal cell population. Global gene expression profiling, pathway analysis, and experimental validation indicate that multiple mechanisms could mediate the tumor-promoting effect of Klf5 deletion, including the up-regulation of epidermal growth factor and its downstream signaling molecules AKT and ERK and the inactivation of the p15 cell cycle inhibitor. KLF5 also appears to cooperate with several transcription factors, including CREB1, Sp1, Myc, ER and AR, to regulate gene expression. These findings validate the tumor suppressor function of KLF5. They also yield a mouse model that shares two common genetic alterations with human prostate cancer-mutation/deletion of Pten and deletion of Klf5.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Wasserstoffperoxid -Lösung, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Wasserstoffperoxid -Lösung, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Wasserstoffperoxid -Lösung, 50 wt. % in H2O, stabilized
Millipore
Wasserstoffperoxid -Lösung, 3%, suitable for microbiology
Supelco
Wasserstoffperoxid -Lösung, ≥30%, for trace analysis
Sigma-Aldrich
Wasserstoffperoxid -Lösung, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
Rapamycin, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
Sigma-Aldrich
Wasserstoffperoxid -Lösung, 34.5-36.5%
Supelco
Wasserstoffperoxid -Lösung, 30 % (w/w), for ultratrace analysis
Supelco
Rapamycin, VETRANAL®, analytical standard
Sigma-Aldrich
Wasserstoffperoxid -Lösung, tested according to Ph. Eur.